Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
YI04 - Basics of Immunology
- 13:30 - 15:00
- 9/08/2019
- Location: Dublin (1997)
- IASLC CME Accredited
- Type: Young Investigator Session
- Track: Young Investigators
- Moderators:Noemi Reguart, Julie R Brahmer
-
+
YI04.01 - PD-L1: Basics of Biology
13:30 - 13:50 | Presenter: Ignacio Gil-Bazo
- Abstract
No abstract available for this presentation
-
+
YI04.02 - Immuno-Oncology Trials: Other Endpoints Needed?
13:50 - 14:10 | Presenter: Martin Reck
- Abstract
Loading... -
+
YI04.03 - The Place of Immunotherapy in NSCLC Therapeutic Algorythm
14:10 - 14:30 | Presenter: Rolf Stahel
- Abstract
Loading... -
+
YI04.04 - How to Select Patients for Immunotherapy
14:30 - 14:50 | Presenter: Naiyer A Rizvi
- Abstract
Loading... -
+
YI04.05 - Q&A
14:50 - 15:00
- Abstract
No abstract available for this presentation
-
+
MA11 - Immunotherapy in Special Populations and Predictive Markers
- 14:00 - 15:30
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Immuno-oncology
- Moderators:Frank Griesinger, Lecia Sequist
-
+
MA11.10 - Peripheral T Cell Repertoire Evolution in Resectable NSCLC Treated with Neoadjuvant PD-1 Blockade
15:05 - 15:10 | Presenter: Justina X Caushi | Author(s): Jiajia Zhang, Zhicheng Ji, Marguerrita El Asmar, Valsamo Anagnostou, Tricia R Cottrell, Hok Yee Chan, Haidan Guo, Taha Merghoub, Jamie E. Chaft, Jedd D Wolchok, Joshua Reuss, Kristen A Marrone, Jarushka Naidoo, Edward Gabrielson, Janis M Taube, Julie R Brahmer, Victor Velculescu, Ni Zhao, Matthew Hellmann, Patrick M. Forde, Drew M Pardoll, Srinivasan Yegnasubramanian, Hongkai Ji, Kellie Smith
- Abstract
Loading... -
+
MA11.11 - STK11/LKB1 Genomic Alterations Are Associated with Inferior Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC
15:10 - 15:15 | Presenter: John Victor Heymach | Author(s): Ferdinandos Skoulidis, Kathryn C. Arbour, Matthew Hellmann, Pradnya Dinkar Patil, Melina E Marmarelis, Dwight Hall Owen, Mark Awad, Joseph C. Murray, Benjamin Philip Levy, Jessica Hellyer, Justin F. Gainor, Tyler Stewart, Sarah B. Goldberg, Anastasios Dimou, Christine M Bestvina, Amy Lauren Cummings, Yasir Elamin, Vincent Lam, Jianjun Zhang, Catherine Shu, Jonathan Wesley Riess, Collin M Blakely, Chad V. Pecot, Laura Mezquita, Fabrizio Tabbò, Adrian G Sacher, Matthias Scheffler, Biagio Ricciuti, Deepti Venkatraman, Hira Rizvi, Corinne Liu, Rocio Perez Johnston, Ying Ni, Joseph Azok, Melanie Wain Kier, Sharyn I Katz, Kurtis D. Davies, Jeremy P Segal, Lauren Ritterhouse, Hiram Shaish, LUDOVIC Lacroix, Regan Memmott, John R Madrigal, Jonathan Goldman, Sally CM Lau, Jonathan Killam, Zenta Walther, Brett Carter, Mark Woodcock, Jack Roth, Stephen Swisher, Natasha B Leighl, Subba Digumarthy, Meghan Mooradian, Julia Rotow, Juergen Wolf, Giorgio Vittorio Scagliotti, David Planchard, Benjamin Besse, Trever G Bivona, David R Gandara, Edward Garon, Naiyer A Rizvi, D. Ross Camidge, Kurt A Schalper, Roy S. Herbst, Alice T. Shaw, Joel W Neal, Heather A Wakelee, Julie R Brahmer, Pasi A Jänne, David P Carbone, Charu Aggarwal, Nathan Pennell, Charles M Rudin, Vassiliki A Papadimitrakopoulou
- Abstract
Loading...
-
+
PC02 - Combining with Chemo: Old School Is New Again
- 14:00 - 15:30
- 9/09/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Pro-Con Session
- Track: Advanced NSCLC
- Moderators:Julien Mazieres, Javier De Castro Carpeno
-
+
PC02.03 - IO Should Be Given as a Single Agent
14:40 - 15:00 | Presenter: Julie R Brahmer
- Abstract
Loading...
-
+
P2.04 - Immuno-oncology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P2.04-24 - Transcriptional Profiling of Neoantigen Specific T Cells in Resectable NSCLC Treated with Neoadjuvant Anti-PD-1
10:15 - 10:15 | Presenter: Justina X Caushi | Author(s): Zhicheng Ji, Jiajia Zhang, Marguerrita El Asmar, Valsamo Anagnostou, Tricia R Cottrell, Hok Yee Chan, Haidan Guo, Taha Merghoub, Jedd D Wolchok, Jarushka Naidoo, Kristen A Marrone, Jamie E. Chaft, Matthew Hellmann, Edward Gabrielson, Janis M Taube, Julie R Brahmer, Victor E Velculescu, Ni Zhao, Patrick M. Forde, Drew M Pardoll, Hongkai Ji, Srinivasan Yegnasubramanian, Kellie Smith
- Abstract
Loading...
-
+
OA14 - Update of Phase 3 Trials and the Role of HPD
- 11:30 - 13:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Oral Session
- Track: Immuno-oncology
- Moderators:Julie R Brahmer, Diego Signorelli
-
+
OA14.01 - KEYNOTE-024 3-Year Survival Update: Pembrolizumab vs Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer
11:30 - 11:40 | Presenter: Martin Reck | Author(s): Delvys Rodríguez-Abreu, Andrew G. Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe, Mary O'Brien, Suman Rao, Katsuyuki Hotta, Tara Garay, Erin Jensen, Victoria Ebiana, Julie R. Brahmer
- Abstract
Loading... -
+
OA14.02 - IMpower131: Final OS Results of Carboplatin + Nab-Paclitaxel ± Atezolizumab in Advanced Squamous NSCLC
11:40 - 11:50 | Presenter: Federico Cappuzzo | Author(s): Robert Jotte, Ihor Vynnychenko, Daniil Stroyakovskiy, Delvys Rodriguez Abreu, Maen Hussein, Ross Soo, Henry J Conter, Toshiyuki Kozuki, KC Huang, Vilma Graupner, Shawn Sun, Tien Hoang, Helen Jessop, Mark McCleland, Marcus Ballinger, Alan Sandler, Mark A Socinski
- Abstract
Loading... -
+
OA14.03 - Clinical Rationale and Preclinical Evidence for Chimeric Antigen Receptor (CAR) T Cell Therapy Clinical Trial in KRAS-Mutant Lung Cancer
11:50 - 12:00 | Presenter: Janna Claire Minehart | Author(s): Takashi Eguchi, Aurore Morello, Prasad S Adusumilli
- Abstract
Loading... -
+
OA14.04 - Five-Year Outcomes From the Randomized, Phase 3 Trials CheckMate 017/057: Nivolumab vs Docetaxel in Previously Treated NSCLC
12:00 - 12:10 | Presenter: Scott Gettinger | Author(s): Hossein Borghaei, Julie R Brahmer, Laura QM Chow, Marco Angelo Burgio, Javier De Castro Carpeno, Adam Pluzanski, Oscar Arrieta, Osvaldo Aren Frontera, Rita Chiari, Charles A Butts, Joanna Wojcik-Tomaszewska, Bruno Coudert, Marina Chiara Garassino, Neal Ready, Enriqueta Felip, Miriam Alonso Garcia, David M Waterhouse, Manuel Dómine, Fabrice Barlesi, Scott J. Antonia, Markus Wohlleber, David E. Gerber, Grzegorz Czyzewicz, David R Spigel, Lucio Crino, Wilfried Ernst Erich Eberhardt, Ang Li, Sathiya Marimuthu, Everett E. Vokes
- Abstract
Loading... -
+
OA14.05 - Discussant - OA14.01, OA14.02, OA14.03, OA14.04
12:10 - 12:25 | Presenter: Jay M Lee
- Abstract
No abstract available for this presentation
-
+
OA14.06 - Hyperprogressive Disease in Advanced Non–Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
12:25 - 12:35 | Presenter: Giuseppe Lo Russo | Author(s): Diego Signorelli, Claudia Proto, Giulia Galli, Arsela Prelaj, Roberto Ferrara, Michele Sommariva, Massimo Moro, Valeria Cancila, Monica Ganzinelli, Silvia Brich, Sabina Sangaletti, Giancarlo Pruneri, Claudio Tripodo, Mario Paolo Colombo, Licia Rivoltini, Andrea Balsari, Gabriella Sozzi, Mattia Boeri, Marina Chiara Garassino
- Abstract
Loading... -
+
OA14.07 - Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced NSCLC Treated with Immunotherapy
12:35 - 12:45 | Presenter: Youjin Kim | Author(s): Chu Hyun Kim, Se-Hoon Lee, Ho Yun Lee, Hong Sook Kim, Kyunga Kim, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park
- Abstract
Loading... -
+
OA14.08 - Discussant - OA14.06, OA14.07
12:45 - 13:00 | Presenter: Kazuhiko Nakagawa
- Abstract
No abstract available for this presentation